Investigative Ophthalmology & Visual Science Cover Image for Volume 60, Issue 9
July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
The Carbon Footprint of Fluorescein Angiography compared to OCT Angiography
Author Affiliations & Notes
  • Rhianon Reynolds
    University Hospital of Wales, United Kingdom
  • Daniel Morris
    University Hospital of Wales, United Kingdom
  • Usha Chakravarthy
    Queens University, Belfast, United Kingdom
  • Footnotes
    Commercial Relationships   Rhianon Reynolds, None; Daniel Morris, None; Usha Chakravarthy, Heidelberg (R), Zeiss (R)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 3050. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rhianon Reynolds, Daniel Morris, Usha Chakravarthy; The Carbon Footprint of Fluorescein Angiography compared to OCT Angiography. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3050.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To estimate the difference in carbon footprint of a novel technology optical coherence topography angiography (OCTA) compared to that of fluorescein angiography (FA), both of which are used in the detection of retinal vascular disease.

Methods : A component analysis of direct and indirect green-house gas (GHG) emissions calculating activity data attributed to patients attending for FA to the University Hospital of Wales (UHW) was carried out. Data was collected for travel, energy use and procurement and reconciled against the established emissions factor; Publicly Available Specification for measurement of GHG emission for goods and services (PAS2050). This allowed calculation of a single GHG equivalent.

Results : OCTA can be carried out at the initial outpatient appointment with no additional visits whilst FA is rarely carried out on the same day and usually requires a second visit. This, in combination with the additional staff required, negatively impacts the GHG emission of FA. Therefore, the additional GHG associated with FA compared to OCTA are as follows: building costs; 40.17KgCO2eq, travel-Staff; 33.03KgCO2eq, patient; 4.27KgCO2eq, pharmaceuticals 1.01 KgCO2eq, medical instrumentation 1.41KgCO2eq and waste 1.24KgCO2eq.
This equates to a total GHG emission of 80.51KgCO2eq per patient. Approximately 850 patients attend for FFA on average each year (UHW). Of these, 300 undertake a same day FA, therefore the additional patient transport can be deducted from the GHG value giving 76.24KGCO2eq. This equates to a carbon foot print of 67.15 tonnesCO2eq per year. Studies have shown a good sensitivity and specificity of OCTA in retinal vascular disease when compared to. If we assume a conservative 50% reduction in the number of FA carried out this would lead to a saving of 34 tonnes CO2eq per year in one hospital and if applied nationwide a notable reduction in the carbon footprint of ophthalmology could be made.

Conclusions : This is the first study to describe the additional GHG emissions associated with FA. Climate change is of upmost global importance and healthcare is responsible for a significant proportion of GHG emissions. Moving from the time consuming and invasive FA to OCTA where possible could produce a notable GHG reduction. This is in addition to the financial cost savings made with fewer hospital appointments and staff costs, and the risk reduction in the avoidance of an invasive procedure.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×